Vertex Pharmaceuticals: Company Passes My Health Check With Flying Colors, Upholding Buy Rating
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
Zacks Investment Research on MSN10h
Editas Q4 Loss Wider Than Expected, Revenues Fall Y/Y, Stock Down
Editas Medicine EDIT reported a loss of 55 cents per share in the fourth quarter of 2024, wider than the Zacks Consensus ...
American Association of Individual Investors1d
Which Is a Better Investment, Riot Platforms, Inc. or Vertex, Inc. Stock?
Learn more about whether Riot Platforms, Inc. or Vertex, Inc. is a better investment based on AAII's A+ Investor grades, ...
Vertex Pharma drops as UnitedHealth offers Tier 3 coverage for new pain medicine
Vertex Pharma (VRTX) stock slips as UnitedHealth (UNH) offers its pain drug Journavx Tier 3 coverage, setting a rivalry with ...
Vertex, Inc. (VERX): Among the Worst Performing Software Stocks to Buy According to Analysts
We recently compiled a list of the 10 Worst Performing Software Stocks to Buy According to Analysts. In this article, we are ...
What is DA Davidson’s Forecast for Vertex FY2025 Earnings?
Stock analysts at DA Davidson decreased their FY2025 earnings estimates for shares of Vertex in a research report issued to clients and investors on Friday, February 28th. DA Davidson analyst W.
Vertex price target lowered to $44 from $55 at BofA
BofA lowered the firm’s price target on Vertex (VERX) to $44 from $55 and keeps a Neutral rating on the shares following Q4 results and an ...
Vertex shares down after Stifel downgrades stock to hold
Inc to “Hold” from “Buy” and lowered its price target to $31 from $35, over the company’s investment strategy and valuation. While Vertex reported solid quarterly, Stifel noted its plan to accelerate ...
Jefferies Financial Group Cuts Vertex (NASDAQ:VERX) Price Target to $48.00
Vertex (NASDAQ:VERX – Free Report) had its target price trimmed by Jefferies Financial Group from $62.00 to $48.00 in a ...